Know Cancer

or
forgot password

Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer


Phase 3
18 Years
N/A
Open (Enrolling)
Both
Rectal Neoplasms

Thank you

Trial Information

Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer


Inclusion Criteria:



- Stage T1 (only)

- Over 18 years old

- Patient's consent

- Previous R0 resection of rectal tumor

Exclusion Criteria:

- Metastases (M1)

- Neoadjuvant chemotherapy or radiotherapy

- Meta- or synchronous tumors

Type of Study:

Interventional

Study Design:

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Recurrence rate

Outcome Time Frame:

5 years

Safety Issue:

No

Principal Investigator

Andreas Zerz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Cantonal Hospital St. Gallen

Authority:

Switzerland: Ethikkommission

Study ID:

EKSG 05/072/2B

NCT ID:

NCT00531297

Start Date:

December 2005

Completion Date:

December 2020

Related Keywords:

  • Rectal Neoplasms
  • Neoplasms
  • Rectal Neoplasms

Name

Location